Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01575938 · ClinicalTrials.gov registry record · NA
HIV Prevention Intervention for Young Transgender Women
A NA study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT01575938 is a NA study that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 300 participants.
The verdict
NCT01575938, a NA study, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
The purpose of this study is to test the efficacy of a uniquely targeted HIV risk reduction intervention for young transgender women (YTW), ages 16 to 29, at risk for HIV acquisition or transmission.
Interventions
- BEHAVIORAL HIV prevention intervention
- BEHAVIORAL Diet and Nutrition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2012-03 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01575938
The ClinicalTrials.gov registry entry for NCT01575938 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which HIV prevention intervention is the first listed.
NCT01575938 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01575938 about?
NCT01575938 is a clinical study titled "HIV Prevention Intervention for Young Transgender Women". The purpose of this study is to test the efficacy of a uniquely targeted HIV risk reduction intervention for young transgender women (YTW), ages 16 to 29, at risk for HIV acquisition or transmission.
What is the current status of trial NCT01575938?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2012-03. Estimated completion is 2016-10.
What interventions are being tested in trial NCT01575938?
The interventions under investigation include: HIV prevention intervention (BEHAVIORAL), Diet and Nutrition (BEHAVIORAL).
Who is sponsoring clinical trial NCT01575938?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.